#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Pericarditis Cholangitis sclerosing B precursor type acute leukaemia Leukodystrophy Ehlers-Danlos syndrome Immunodeficiency Acute graft versus host disease in intestine Retinal dystrophy Pleomorphic liposarcoma Superficial vein thrombosis Hairy cell leukaemia recurrent Basal cell naevus syndrome Hodgkin's disease Glioblastoma multiforme More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Diagnostics Urea cycle disorder Mucopolysaccharidosis I – Trials in Disease Proteus syndrome – Basic Information Propionic acidaemia – Life with Disease Hereditary ataxia – Trials in Disease Skin angiosarcoma – Diagnostics Fabry’s disease – Life with Disease Pleural mesothelioma malignant – Treatment Mantle cell lymphoma stage IV – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jnj-64042056 Raltegravir Febuxostat SILYMARIN Iph6501 Dapagliflozin Holcus Lanatus Pollen Extract Midazolam Hydrochloride Odronextamab Hyoscine Butylbromide Resiquimod Sulfate R3R01 VINBLASTINE Flecainide Acetate Bi 765845 Levocabastine Hydrochloride Tirzepatide Camizestrant Zenocutuzumab Mycophenolate Mofetil More therapies…

    Learn about Your Condition

    Ehlers-Danlos syndrome Cortical dysplasia Pulmonary venous thrombosis Ovarian cancer metastatic Hyperoxaluria Joint stabilisation Implantation complication Cardiac failure Metabolic disorder Stress cardiomyopathy Retinal artery occlusion Aortic valve stenosis Adenovirus infection Type 1 diabetes mellitus Mantle cell lymphoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pertussis

  • Study of acellular pertussis vaccine and its effect on whooping cough colonization in healthy adults using controlled human infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pertussis
    Investigated Drugs:
    • Azithromycin
    • TETANUS TOXOID
    The Netherlands
  • Study on How Vaccines Affect Infant Immunity to Whooping Cough in Babies Born to Vaccinated Mothers Using Diphtheria, Tetanus, and Pertussis Vaccine Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pertussis
    Investigated Drugs:
    • HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE
    • HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PRODUCED IN S. CEREVISIAE BY RDNA]
    • TETANUS TOXOID
    Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!